Medifocus Inc V.MFS

LOSS IS GETTING SMALLER

[Highrider7]

  As seen in the financial statements the " loss per share " is dropping .  What they have to do is concentrate on pushing ahead on their sales end and keep having the loss drop more with each coming quarter.  Obviously more sales means less losses providing they keep their spending under control 

(n) Earnings per share

 

Basic earnings (loss) per share is computed by dividing net earnings (loss) by the weighted average number of common shares outstanding for the period

For the Three			For the Three			For the Nine			For the Nine
Months Ended			Months Ended			Months Ended			Months Ended
December 31, 2013			December 31, 2012			December 31, 2013			December 31, 2012
restated [note 166]						restated [note 16]
$			$			$			$
Revenue		1,346,979			630,150		3,892,178			943,431
Cost of sales	498,084			206,946		1,342,952		312,079			2,002,178.12
Amortization of intangible assets - Prolieve intellectual property   [note 7]	95,890			—		287,670		—			1.059353503
Gross margin		753,005			423,204		2,261,557			631,352
Operating expenses
Salaries and wages		897,098			676,090		2,445,515			1,086,483
Development and investor relations		75,901			695,819		213,454			926,718
Stock based compensation expense   [note 14d]		—			40,000		112,218			40,000
Sales and marketing		409,134			—		1,221,279			—
Management fees   [note 14]		18,750			284,550		278,450			378,750
Research and development expense   [note 16]	106,993			335,778		508,488		495,417			55987.5
Professional fees		368,347			139,908		718,313			443,418
Directors fees   [note 14]		43,750			133,750		131,250			221,250
Accretion   [note 11]		37,325			—		111,975			—
General and administrative		154,923			69,395		465,847			189,176
Interest   [note 11 ]		71,904			48,556		153,841			131,202
Listing fees		10,938			16,117		23,973			78,279
Amortization   [note 8]		2,440			3,211		7,320			5,919
2,197,503		2,443,174			6,391,923		3,996,612			3,836,971
Net loss before other income	(1,444,498)			(2,019,970)		(4,130,366)		(3,365,260)			159,641
Foreign exchange gain (loss)		(93,227)			(40,874)		(109,271)			(130,559)
Net loss and comprehensive loss		(1,537,725)			(2,060,844)		(4,239,637)			(3,495,819)
Basic and fully diluted loss per share		(0.013)			(0.021)		(0.036)			(0.036)
Weighted average number of common
shares outstanding		117,260,411			96,949,246		117,260,411			96,949,246